Alpha pharma
ActiveDirectors
Directors
1 director, last change in 2024
Board 1
JM
Current
Director (not named in the articles) · appointed in the act of 02-10-2024 · term without a fixed end · Legal entity · permanent representative: PRINCEN Johanna · listed in the 2025 annual accounts, filed on 23-06-2026
Permanent representatives 1
PRINCEN Johanna
Current
Permanent representative · appointed in the act of 02-10-2024 · for JM
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Each director alone
deed of 02-10-2024Owners and capital
Shareholders
1 ownerChain of control
- JM
- Alpha pharma
Owners 1
- JMparentSourceaccounts JM 2025Equity €10,000 Profit of €113,726 in 2025 (profit of €79,469 in 2024) Checked score 8880%
Capital transactions
Shareholders according to the deeds
Stated in the act
act of 02-10-2024 ↗
- PRINCEN Johanna 372 shares
- JM 1,488 shares
Capital over time
- 02-10-2024 Converted to unavailable equity · €18,600
- 02-10-2024 Converted to unavailable equity · €1,860
- 02-10-2024 Converted to available equity · €18,600
- 02-10-2024 Converted to available equity · €1,860
Mandate history
5 people, 1 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| JM |
|
| DEQUAE Anna |
|
| PRINCEN Filip |
|
| PRINCEN Johanna |
|
| Princen Bert |
|
Articles of association
- Kind of sharesThe articles set which classes of shares exist and what rights each class carries.
- “1 stem per aandeel, ongewijzigd en gelijk voor zowel soort A als voor soort B”
- Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
- “Tenzij de akte van benoeming of de rechterlijke uitspraak anders bepalen, is de vereffenaar bevoegd voor alle handelingen die nodig of…”
Articles of association, deed of 02-10-2024 (in Dutch)